Downregulation of SNCA Expression as a Therapoetic Approach for Parkinson's Disease and Other Synucleinopathies: New Target Validation for Next-Generation Drug Discovery

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Kantor, B; Dong, W; Rittiner, J; Poe, J; Chiba-Falek, O

Published Date

  • April 27, 2021

Published In

Volume / Issue

  • 29 / 4

Start / End Page

  • 265 - 266

Electronic International Standard Serial Number (EISSN)

  • 1525-0024

International Standard Serial Number (ISSN)

  • 1525-0016